September 2009 - Wadsworth Center

Summary:Table 3. Summary of Laboratories Performance September 2009 PT EventAcceptable Responses/Total # Laboratories (%)S- 1: Candida parapsilosis M957Amphotericin B 26/26(100)Anidulafungin 16/16 (100)Caspofungin 21/21 (100)Flucytosine (5-FC) 25/25 (100)Fluconazole 31/31 (100)Itraconazole 28/28 (100)Ketoconzole 6/6 (100)Micafungin 15/15 (100)Posaconazole 17/17 (100)Voriconazole 23/23 (100)Table 4. Distribution of MIC (µg/ml) Reported by Participating Laboratories Using TREK Diagnostic System SensititreYeastOne Panel, Etest, NCCLS Broth Microdilution MethodS-1: Candida parapsilosis M957Drugs (µg/ml) Total # of labs 0.008 0.015 0.016 0.023 0.03 0.047 0.06 0.1 0.12 0.25 0.5 0.75 1.0 2.0 4.0Amphotericin B 26 2 7 14 1 2Anidulafungin 16 14 2Caspofungin 21 12 8 1Flucytosine (5-FC) 25 2 1 14 1 5 1 1Fluconazole 31 6 17 7 1Itraconazole 28 1 1 1 2 19 4Ketoconazole 6 2 1 1 2Micafungin 15 1 2 11 1Posaconazole 17 1 11 4 1Voriconazole 23 7 11 3 1 152